Abstract

The aim is to examine the association of lifecourse socioeconomic position (SEP) on circulating levels of D-dimer. Data from the 1958 British birth cohort were used, social class was determined at three stages of respondents' life: at birth, at 23 and at 42 years. A cumulative indicator score of SEP (CIS) was calculated ranging from 0 (always in the highest social class) to 9 (always in the lowest social class). In men and women, associations were observed between CIS and D-dimer (P<0.05). Thus, the respondents in more disadvantaged social classes had elevated levels of D-dimer compared to respondents in less disadvantaged social class. In multivariate analyses, the association of disadvantaged social position with D-dimer was largely explained by fibrinogen, C-reactive protein and von Willebrand Factor in women, and additionally by smoking, alcohol consumption and physical activity in men. Socioeconomic circumstances across the lifecourse at various stages also contribute independently to raised levels of D-dimer in middle age in women only. Risk exposure related to SEP accumulates across life and contributes to raised levels of D-dimer. The association of haemostatic markers and social differences in health may be mediated by inflammatory and other markers.

Highlights

  • Fibrin D-dimer, the most commonly used clinical assay of coagulation activation and in vivo fibrin formation and lysis in circulating blood has been associated with increased risk of cardiovascular disease

  • A meta-analysis of prospective studies [1] showed an association of circulating levels of fibrin D-dimer with coronary heart disease (CHD) that appeared of similar strength to that of fibrinogen

  • We examined whether the association of D-dimer with socioeconomic position (SEP) is cumulative, i.e. the increased exposure to adverse SEP is associated with raised levels of D-dimer and whether the associations between the accumulation of SEP and D-dimer were attributable to major risk factors for CHD

Read more

Summary

Introduction

Fibrin D-dimer, the most commonly used clinical assay of coagulation activation and in vivo fibrin formation and lysis in circulating blood has been associated with increased risk of cardiovascular disease. A meta-analysis of prospective studies [1] showed an association of circulating levels of fibrin D-dimer with coronary heart disease (CHD) that appeared of similar strength to that of fibrinogen (a biochemical marker of an existing thrombophilia, which is correlated in part due to associations with asymptomatic and symptomatic arterial lesions [2]). Elevated D-dimer values occur in various disorders in which the coagulation system is excessively activated, such as acute venous thromboembolism [6,7]. High plasma levels of D-dimer have been associated with the incidence of cardiovascular disease [1,2,8,9,10,11,12,13], and vascular dementia [14,15]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call